Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital
- 5 October 2016
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 95 (4) , 918-924
Abstract
Histoplasmosis is common among persons living with human immunodeficiency virus/acquired immune deficiency syndrome (PLWHA) in Latin America, but its diagnosis is difficult and often nonspecific. We conducted prospective screening for histoplasmosis among PLWHA with signs or symptoms suggesting progressive disseminated histoplasmosis (PDH) and hospitalized in Hospital La María in Medellín, Colombia. The study's aim was to obtain a clinical and laboratory profile of PLWHA with PDH. During 3 years (May 2008 to August 2011), we identified 89 PLWHA hospitalized with symptoms suggestive of PDH, of whom 45 (51%) had histoplasmosis. We observed tuberculosis (TB) coinfection in a large proportion of patients with PDH (35%), so all analyses were performed adjusting for this coinfection and, alternatively, excluding histoplasmosis patients with TB. Results showed that the patients with PDH were more likely to have Karnofsky score ≤ 30 (prevalence ratio [PR] = 1.98, 95% confidence interval [CI] = 0.97–4.06), liver compromised with hepatomegaly and/or splenomegaly (PR = 1.77, CI = 1.03–3.06) and elevation in serum of alanine aminotransferase and aspartate aminotransferase to values > 40 mU/mL (PR = 2.06, CI = 1.09–3.88 and PR = 1.53, CI = 0.99–2.35, respectively). Using multiple correspondence analyses, we identified in patients with PDH a profile characterized by the presence of constitutional symptoms, namely weight loss and Karnofsky classification ≤ 30, gastrointestinal manifestations with alteration of liver enzymes and hepatosplenomegaly and/or splenomegaly, skin lesions, and hematological alterations. Study of the profiles is no substitute for laboratory diagnostics, but identifying clinical and laboratory indicators of PLWHA with PDH should allow development of strategies for reducing the time to diagnosis and thus mortality caused by Histoplasma capsulatum.Keywords
This publication has 33 references indexed in Scilit:
- Disseminated Histoplasmosis in HIV-Infected Patients in South America: A Neglected Killer Continues on Its RampagePLOS Neglected Tropical Diseases, 2013
- Methodology for Definition of Yellow Fever Priority Areas, Based on Environmental Variables and Multiple Correspondence AnalysesPLOS Neglected Tropical Diseases, 2012
- HistoplasmosisProceedings of the American Thoracic Society, 2010
- Assessment of Yellow Fever Epidemic Risk: An Original Multi-criteria Modeling ApproachPLOS Neglected Tropical Diseases, 2009
- Development and Evaluation of an Enzyme-Linked Immunosorbent Assay To DetectHistoplasma capsulatumAntigenuria in Immunocompromised PatientsClinical and Vaccine Immunology, 2009
- Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapyDiagnostic Microbiology and Infectious Disease, 2008
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Histoplasmosis: a Clinical and Laboratory UpdateClinical Microbiology Reviews, 2007
- Disseminated histoplasmosis in HIV positive patients in Espírito Santo state, Brazil: a clinical-laboratory study of 12 cases (1999-2001)The Brazilian Journal of Infectious Diseases, 2006
- Histoplasmosis Among Human Immunodeficiency Virus-Infected People in EuropeMedicine, 2006